170 related articles for article (PubMed ID: 38586813)
1. Long-Term Follow-Up of Combination Therapy with Sintilimab and Anlotinib in Gallbladder Follicular Dendritic Cell Sarcoma: A Rare Case Report.
Yan J; Zhang X; Yu L; Ye M; Chen Y
Onco Targets Ther; 2024; 17():287-295. PubMed ID: 38586813
[TBL] [Abstract][Full Text] [Related]
2. Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic follicular dendritic cell sarcoma of the spleen: a case report.
Li J; Ren M; Bi F; Chen Y; Li Z
Front Immunol; 2023; 14():1228653. PubMed ID: 37691960
[TBL] [Abstract][Full Text] [Related]
3. Unexpected Favorable Outcome to PD-1 Antibody Plus Lenvatinib in a Patient With Recurrent Intestinal Follicular Dendritic Cell Sarcoma: A Case Report and Literature Review.
Lei Y; Zhao S; Jiang M
Front Immunol; 2021; 12():653319. PubMed ID: 34566950
[TBL] [Abstract][Full Text] [Related]
4. Response of Tonsil Follicular Dendritic Cell Sarcoma to Multimodal Treatment Including Pembrolizumab: A Case Report and Literature Review.
Chen N; Ba W; Zhao D; Sheng L; Zhang X
Front Oncol; 2022; 12():816903. PubMed ID: 35299752
[TBL] [Abstract][Full Text] [Related]
5. Interdigitating and follicular dendritic cell sarcomas: a SEER analysis.
Perkins SM; Shinohara ET
Am J Clin Oncol; 2013 Aug; 36(4):395-8. PubMed ID: 22772431
[TBL] [Abstract][Full Text] [Related]
6. Intra-abdominal Follicular Dendritic Cell Sarcoma (FDCS): Series of 18 cases of a rare entity from Pakistan.
Zubair M; Din NU; Arshad S; Minhas K; Idress R; Ahmad Z
Ann Diagn Pathol; 2020 Dec; 49():151595. PubMed ID: 32905993
[TBL] [Abstract][Full Text] [Related]
7. Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma.
Shah P; Shah S; Agostino N
Case Rep Oncol; 2020; 13(3):1131-1135. PubMed ID: 33082759
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary diagnosis and treatment of recurrent follicular dendritic cell sarcoma in abdomen: A case report.
Qu C; Tian X; Ma Y; Xie X; Wang M; Dong Y; Zhang J; Liu P; Yang Y
Medicine (Baltimore); 2020 Dec; 99(51):e23588. PubMed ID: 33371089
[TBL] [Abstract][Full Text] [Related]
9. Postoperative liver metastasis of primary inflammatory pseudotumorous follicular dendritic cell sarcoma of the spleen: a case report.
Pang RH; Zhu YQ; Wu J; Huang JH; Chen B
Ann Palliat Med; 2021 Aug; 10(8):9297-9303. PubMed ID: 34488416
[TBL] [Abstract][Full Text] [Related]
10. Follicular dendritic cell sarcoma treated with a variety of chemotherapy.
Sasaki M; Izumi H; Yokoyama T; Kojima M; Hosono A
Hematol Oncol; 2017 Dec; 35(4):905-908. PubMed ID: 27734516
[TBL] [Abstract][Full Text] [Related]
11. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas.
Gounder M; Desai V; Kuk D; Agaram N; Arcila M; Durham B; Keohan ML; Dickson MA; D'Angelo SP; Shukla N; Moskowitz C; Noy A; Maki RG; Herrera DA; Sanchez A; Krishnan A; Pourmoussa A; Qin LX; Tap WD
Eur J Cancer; 2015 Nov; 51(16):2413-22. PubMed ID: 26298731
[TBL] [Abstract][Full Text] [Related]
12. Primary hepatic follicular dendritic cell sarcoma: A case report.
Chen HM; Shen YL; Liu M
World J Clin Cases; 2019 Mar; 7(6):785-791. PubMed ID: 30968045
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation.
Cao JZ; Wu W; Pan JF; Wang HW; Jiang JH; Ma Q
Front Oncol; 2021; 11():643413. PubMed ID: 34109111
[TBL] [Abstract][Full Text] [Related]
14. Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC.
Chu T; Zhong R; Zhong H; Zhang B; Zhang W; Shi C; Qian J; Zhang Y; Chang Q; Zhang X; Dong Y; Teng J; Gao Z; Qiang H; Nie W; Zhao Y; Han Y; Chen Y; Han B
J Thorac Oncol; 2021 Apr; 16(4):643-652. PubMed ID: 33524601
[TBL] [Abstract][Full Text] [Related]
15. Intracranial complete response to toripalimab and anlotinib in a patient with recurrent brain metastases of small cell lung cancer after failure of second-line maintenance therapy: a case report.
Huang F; Tang J; Lou J; Wang Q; Ma K; Qiao R; Si J; Kang Y; Chen H; Mei J; Wang H; Liu Y; Miao L
Transl Cancer Res; 2022 Sep; 11(9):3337-3342. PubMed ID: 36237231
[TBL] [Abstract][Full Text] [Related]
16. [Clinical pathologic characteristics of extranodal follicular dendritic cell sarcoma].
Cui LF; Zhang JX; Li Z; Gao Y; Lu T; Zhao HY; Zhong DR
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):218-222. PubMed ID: 30917459
[No Abstract] [Full Text] [Related]
17. Follicular Dendritic Cell Sarcoma of the Tonsil: A Multimodality Approach.
King REC; Villaruel AR; Magno JPM; de Guzman SPC; Catedral LIG; Mondragon KAM; Ting FIL; Velasco RN; Fernando GY
J Med Cases; 2020 Oct; 11(10):309-316. PubMed ID: 34434336
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal follicular dendritic cell sarcoma: role of chemotherapy and bone marrow allotransplantation in locally advanced disease?
Liberale G; Keriakos K; Azerad M; De Saint Aubain N; El Nakadi I
Clin Med Insights Oncol; 2015; 9():9-13. PubMed ID: 25698886
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis in patients with follicular dendritic cell sarcoma: a population-based study.
Chen S; Sun Y; Sun W; Dan M; Jiang Y
Hematology; 2023 Dec; 28(1):2260975. PubMed ID: 37732620
[TBL] [Abstract][Full Text] [Related]
20. Anlotinib plus Sintilimab achieved in an antitumor effect of complete remission in a patient with advanced hepatocellular carcinoma: a case report.
Sun C; Ma X; Jiang L; Zhu X
Anticancer Drugs; 2024 Apr; 35(4):358-361. PubMed ID: 38385998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
